Jubilant Ingrevia hits 14-quarter profit high on volume recovery
Revenue rose 12% to ₹1,179 crore as the company worked through supply disruptions. Management expects sequential growth to continue into FY27.
— 4 earlier stories on Jubilant Ingrevia Ltd. →What's new
- Q4 revenue climbed 12% YoY to ₹1,179 crore, aided by 10% volume growth.
- EBITDA rose 11% to ₹172 crore; net profit grew 17% to ₹86 crore.
- The company commissioned a new agro CDMO facility and expects sequential growth in Q1FY27.
Why this matters
The results mark a return to growth after three years of profit stagnation. Sustaining this depends on whether the recovery in acetyls pricing holds against chemical sector volatility.
What we're watching
- Whether the new agro CDMO facility contributes to margins in Q1.
- The pace of demand recovery in the acetyls segment.
- Execution of the guided sequential growth in the coming quarter.
The full read
Jubilant Ingrevia posted its strongest quarterly performance in 14 quarters, with net profit rising 17% to ₹86 crore for the period ended March 31, 2026. Consolidated revenue grew 12% to ₹1,179 crore, underpinned by 10% volume growth and better pricing in the final months of the quarter. EBITDA followed the trend, climbing 11% to ₹172 crore. The company brought a new agro CDMO facility online while avoiding production hits from Middle East supply chain issues. Management now points toward sequential growth in both revenue and earnings for Q1FY27, citing a recovery in acetyls demand and consistent performance in its specialty chemicals and nutrition divisions. These results confirm a return to growth after a period of flat earnings.
Questions answered
- What drove the 12% revenue growth in the March quarter?
- Revenue growth came from a 10% increase in volumes and improved pricing during the second half of the quarter.
- How did the company handle Middle East supply disruptions?
- Jubilant Ingrevia avoided production losses despite the disruptions in the region.
- What is the management outlook for the next financial year?
- Management expects sequential revenue and earnings growth starting from Q1FY27, supported by recovery in acetyls and momentum in specialty chemicals.
- How significant is the current profit level?
- The reported net profit of ₹86 crore is the highest quarterly profit the company has recorded in 14 quarters.
Story so far
All notes on JUBLINGREA →- 26 May 2026 · 3:00 PM IST Jubilant Ingrevia hits 14-quarter profit high on volume recovery
- 1d ago Jubilant Ingrevia's Q4 call transcript is out. It adds nothing new.
- 4d ago Jubilant Ingrevia's $300M agro client faces financial distress
- 4d ago Jubilant Ingrevia hits 14-quarter revenue high on 12% growth
- 4d ago Jubilant Ingrevia reports 5% revenue growth for FY26